MG
Mark A Goldsmith (See Remarks) filed 11 Form 4 reports in the trailing twelve months (0 purchases, 11 sales), most often in Revolution Medicines, Inc. (RVMD). The largest single filing was $18.0M of RVMD (120,000 sh × $150.09, as filed), executed Apr 15. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
11
0 buys · 11 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$45.8M
shares × price, as filed
Last traded
Sep 16
Filed Sep 18
Median ADV $548.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $58.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
10 filings
Sector per market data · by filing · past 12 months
Most traded names
RVMDRecent filings
RVMDSALE
Revolution Medicines, Inc.
View filing →
$3.9M70,000 sh across 4 lots
Exec Nov 1 2024
Filed Nov 5 2024 · 5:30 PM ET